We are live on ! Find out more
MC

Moors & Cabot Portfolio holdings

AUM $2.34B
1-Year Est. Return 30.42%
This Fund
S&P 500
This Quarter Est. Return
+9.05%
1 Year Est. Return
+30.42%
3 Year Est. Return
+101.7%
5 Year Est. Return
+135.96%
10 Year Est. Return
+427.28%
AUM
$1.06B
AUM Growth
+$124M
Cap. Flow
+$63.5M
Cap. Flow %
5.98%
Top 10 Hldgs %
22.6%
Holding
755
New
85
Increased
278
Reduced
300
Closed
48

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.11M
2
PEP icon
PepsiCo
PEP
+$2.05M
3
QGEN icon
Qiagen
QGEN
+$1.86M
4
NVDA icon
NVIDIA
NVDA
+$1.8M
5
MSFT icon
Microsoft
MSFT
+$1.62M

Sector Composition

Rank Sector Weight
1 Technology 20.24%
2 Healthcare 13.55%
3 Industrials 8.96%
4 Financials 8.85%
5 Consumer Staples 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJH icon
226
iShares Core S&P Mid-Cap ETF
IJH
$123B
$892K 0.08%
24,055
-16,345
-40% -$611K
RSP icon
227
Invesco S&P 500 Equal Weight ETF
RSP
$96.3B
$892K 0.08%
8,243
-4,040
-33% -$436K
IRM icon
228
Iron Mountain
IRM
$38.2B
$891K 0.08%
33,253
+10,063
+43% +$286K
CNP icon
229
CenterPoint Energy
CNP
$29.1B
$885K 0.08%
45,748
-584
-1% -$11.5K
MINT icon
230
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$871K 0.08%
8,539
+3,145
+58% +$320K
FISV
231
Fiserv Inc
FISV
$27.2B
$870K 0.08%
8,440
+20
+0.2% +$1.99K
WHR icon
232
Whirlpool
WHR
$2.42B
$864K 0.08%
4,699
-1,536
-25% -$255K
CLX icon
233
Clorox
CLX
$11.6B
$859K 0.08%
4,084
-162
-4% -$36.1K
TLT icon
234
iShares 20+ Year Treasury Bond ETF
TLT
$42.6B
$858K 0.08%
5,256
+206
+4% +$34.2K
CB icon
235
Chubb
CB
$140B
$848K 0.08%
7,304
+404
+6% +$50.7K
XLV icon
236
State Street Health Care Select Sector SPDR ETF
XLV
$42B
$847K 0.08%
8,023
-78
-1% -$8.21K
XLF icon
237
State Street Financial Select Sector SPDR ETF
XLF
$56.1B
$844K 0.08%
35,074
-5,713
-14% -$139K
DG icon
238
Dollar General
DG
$25.9B
$829K 0.08%
3,952
-26
-0.7% -$5.11K
ADP icon
239
Automatic Data Processing
ADP
$100B
$828K 0.08%
5,938
+735
+14% +$103K
MAR icon
240
Marriott International
MAR
$98.7B
$826K 0.08%
8,922
+3,070
+52% +$290K
AGI icon
241
Alamos Gold
AGI
$12.4B
$820K 0.08%
93,038
+999
+1% +$10.1K
PHG icon
242
Philips
PHG
$25.4B
$806K 0.08%
21,060
+2,049
+11% +$82.2K
KEYS icon
243
Keysight
KEYS
$54.5B
$800K 0.08%
8,100
CNI icon
244
Canadian National Railway
CNI
$78.3B
$798K 0.08%
7,495
+58
+0.8% +$5.83K
NUV icon
245
Nuveen Municipal Value Fund
NUV
$1.91B
$786K 0.07%
73,777
-5,000
-6% -$52.9K
PPL
246
PPL Corp
PPL
$27.3B
$786K 0.07%
28,876
-452
-2% -$12.2K
ESI icon
247
Element Solutions
ESI
$9.12B
$785K 0.07%
74,700
-1,900
-2% -$20.8K
DHR icon
248
Danaher
DHR
$135B
$781K 0.07%
4,090
+38
+0.9% +$6.76K
ZM icon
249
Zoom
ZM
$25.8B
$779K 0.07%
1,657
+30
+2% +$9.59K
CHCT
250
Community Healthcare Trust
CHCT
$537M
$775K 0.07%
16,582
-559
-3% -$25.6K

Similar funds

Moors & Cabot's Q3 2020 Portfolio in Review

As of Q3 2020, Moors & Cabot held 755 positions worth $1.06B, up 13% from $939M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Moors & Cabot deployed $63.5M of net new capital in Q3 2020, opening 85 new positions and adding to 278 existing holdings. Its largest new stake was Qiagen: 35,861 shares worth $1.99M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Union Pacific, an estimated $1.34M trimmed.

  • Moors & Cabot's largest Q3 2020 buy was Qiagen: 35,861 shares worth $1.99M.
  • Moors & Cabot added most to Pfizer in Q3 2020, an estimated $2.11M increase.
  • Moors & Cabot's biggest Q3 2020 reduction was Union Pacific, cutting an estimated $1.34M.
  • Moors & Cabot fully exited SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML) in Q3 2020, selling an estimated $753K.
  • Moors & Cabot's ten largest holdings make up 23% of its $1.06B portfolio in Q3 2020.
  • Moors & Cabot opened 85 new positions and closed 48 in Q3 2020.
  • Moors & Cabot's portfolio value rose 13% quarter-over-quarter to $1.06B.

Based on Moors & Cabot's 13F filing for Q3 2020, filed 9 Nov 2020.